Mogamulizumab (Anti-CCR4 / CD194)

Synonyms: KW-0761

Catalog No.A2568 Purity:99%

Mogamulizumab (Anti-CCR4 / CD194) is a defucosylated humanized recombinant monoclonal antibody targeting CCR4. Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL). MW:145.5 KD.

Purity & Quality Control

Batch: A256801 Purity: 99% Protein concentration: 6.86mg/ml Endotoxin Level: ＜1EU/mg

Choose Selective CCR Inhibitors

Name	Citation	CCR	CCR1	CCR2	CCR3	CCR4	CCR5	CCR9	CCL	Others
SB-328437	0				++
INCB3344	4			++						mCCR2
RS504393	0			+
C-021	0					+
Vercirnon	0							+++
BX471	1		++++
PF-4136309	0			++
Vicriviroc maleate	1	+++					+++
RS-102895 Hydrochloride	0			+						human α1a receptor,human α1d receptor,5-HT1a receptor
RS102895	2			+
TAK-779	0	++++					++++			CXCR3
AZD2098	1					++
Adaptavir (DAPTA)	3	++++					++++
R243	✔
Perillaldehyde								✔	NRF2/HO1,ROS,AhR
Cenicriviroc			✔						HIV-2,HIV-1
Isuzinaxib (APX-115 free base)								✔	TNFα,IL-6,NOX2
SB-297006				✔
BMS-813160			✔
Bindarit								✔

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description	Mogamulizumab (Anti-CCR4 / CD194) is a defucosylated humanized recombinant monoclonal antibody targeting CCR4. Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL). MW:145.5 KD.

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1159266-37-1
Molecular Weight	144.12 kDa
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

* Name Please enter your name.

* Email Please enter your email. Please enter a valid email address.

Phone

* Comments: Please write something to us.

Tags: buy Mogamulizumab (Anti-CCR4 / CD194) | Mogamulizumab (Anti-CCR4 / CD194) supplier | purchase Mogamulizumab (Anti-CCR4 / CD194) | Mogamulizumab (Anti-CCR4 / CD194) cost | Mogamulizumab (Anti-CCR4 / CD194) manufacturer | order Mogamulizumab (Anti-CCR4 / CD194) | Mogamulizumab (Anti-CCR4 / CD194) distributor